According to the report, the sale proceeds will be approximately $98 million including estimated net working capital. The deal is expected to close by September 2012, pending regulatory approvals.
More Articles on Pennsylvania Hospital Transactions:
Highmark, West Penn Merger Gets Public Support in Hearing
Pennsylvania State Senator Opposes Prime Healthcare, Roxborough Memorial Deal
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
